...
首页> 外文期刊>European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V >Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release
【24h】

Effect of co-administration of probiotics with polysaccharide based colon targeted delivery systems to optimize site specific drug release

机译:益生菌与多糖的结肠靶向递送系统共同施用的影响优化现场特异性药物释放

获取原文
获取原文并翻译 | 示例
           

摘要

Significant clinical success of colon targeted dosage forms has been limited by their inappropriate release profile at the target site. Their failure to release the drug completely in the colon may be attributed to changes in the colonic milieu because of pathological state, drug effect and psychological stress accompanying the diseased state or, a combination of these. Alteration in normal colonic pH and bacterial picture leads to incomplete release of drug from the designed delivery system. We report the effectiveness of a targeted delivery system wherein the constant replenishment of the colonic microbiota is achieved by concomitant administration of probiotics along with the polysaccharide based drug delivery system. Guar gum coated spheroids of sulfasalazine were prepared. In the dissolution studies, these spheroids showed markedly higher release in the simulated colonic fluid. In vivo experiments conducted in rats clearly demonstrated the therapeutic advantage of co-administration of probiotics with guar gum coated spheroids. Our results suggest that concomitant use of probiotics along with the polysaccharide based delivery systems can be a simple strategy to achieve satisfactory colon targeting of drugs. (C) 2015 Elsevier B.V. All rights reserved.
机译:结肠靶向剂型的显着临床成功受到靶位部位的不适当释放曲线的限制。由于病理状态,伴随患病状态的病理状态,药物效应和心理胁迫,或者,它们的患者可能归因于结肠内核的变化,或者伴随着患病状态的药物效应和心理压力。正常结肠pH和细菌图像的改变导致来自设计的送货系统的药物不完全释放。我们报告了靶向递送系统的有效性,其中通过伴随益生菌和基于多糖的药物递送系统来实现结肠微生物生物的恒定补充。制备瓜尔甘蔗碱的瓜尔胶涂层球体。在溶解研究中,这些球状体在模拟结肠流体中显示出明显较高的释放。在大鼠中进行的体内实验清楚地证明了用瓜尔胶涂覆的球状体共同施用益生菌的治疗优势。我们的研究结果表明,伴随益生菌以及基于多糖的递送系统可以是实现令人满意的冒毒靶向药物的简单策略。 (c)2015 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号